Global Atherectomy Devices Market : Size, Share, Growth Analysis and - Global Forecasts To 2022

on

Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022

 Some of the factors driving the growth of this market are the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers. 

 However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.
The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from 1.08 Billion in 2017, at a CAGR of 6.1%. 
Analysis of the market developments between 2014 and 2017 (October) reveals that several growth strategies such as product launches, strategic acquisitions, mergers, market expansions, agreements, partnerships, and collaborations are adopted by the market players to strengthen their product portfolios and maintain a competitive position in the atherectomy devices market. Among these business strategies, product launches and strategic acquisitions were the most widely adopted growth strategies by players in the market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.
The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Comments

Post a Comment